Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EURONET WORLDWIDE, INC.EEFT · Entity 4336 | Director · CEO & President | February 26, 2026 | March 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EURONET WORLDWIDE, INC.
Report date February 26, 2026 · Filed March 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.02 per shareSEC Table I · non-derivative | Direct | 1,450,716 |
Ending reported balance
After 2026-02-26 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-26 · Grant · Acquired 54,949 · Balance 1,475,133 F1: Vesting of shares from performance-based stock awards granted on December 7, 2021 (3,935), December 6, 2022 (40,345), December 12, 2023 (5,675) and December 10, 2024 (4,994). Row 2 · 2026-02-26 · Tax withholding · Disposed 24,417 · Balance 1,450,716 F2: Represents shares surrendered to Euronet Worldwide, Inc. by the Reporting Person to satisfy tax withholding liability obligations associated with the vesting of performance-based restricted stock. |
| Common Stock, par value $0.02 per shareSEC Table I · non-derivative | IndirectBy 401(k) Plan | 5,960 |
Reported balance
Holding disclosure · report date 2026-02-26 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 5,960 |
| Common Stock, par value $0.02 per shareSEC Table I · non-derivative | IndirectSee | 211,248 |
Reported balance
Holding disclosure · report date 2026-02-26 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 211,248 F3: Shares held by Mr. Brown's spouse as custodian for his children. |
| Common Stock, par value $0.02 per shareSEC Table I · non-derivative | IndirectBy Family Trusts | 171,400 |
Reported balance
Holding disclosure · report date 2026-02-26 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 171,400 F4: Shares held by family trusts for the benefit of Mr. Brown's spouse and children, of which Mr. Brown's spouse is the trustee. |
| Common Stock, par value $0.02 per shareSEC Table I · non-derivative | IndirectBy Spouse | 158,715 |
Reported balance
Holding disclosure · report date 2026-02-26 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 158,715 |
Filing footnotes · ownership attribution and instrument terms
F1: Vesting of shares from performance-based stock awards granted on December 7, 2021 (3,935), December 6, 2022 (40,345), December 12, 2023 (5,675) and December 10, 2024 (4,994).
F2: Represents shares surrendered to Euronet Worldwide, Inc. by the Reporting Person to satisfy tax withholding liability obligations associated with the vesting of performance-based restricted stock.
F3: Shares held by Mr. Brown's spouse as custodian for his children.
F4: Shares held by family trusts for the benefit of Mr. Brown's spouse and children, of which Mr. Brown's spouse is the trustee.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Monopar Therapeutics
Report date September 24, 2025 · Filed September 26, 2025
Jointly reported with Tactic Pharma LLC, Robinson Chandler, O'Halloran Thomas V., Mazar Andrew Paul
Section 16 reporting ended · disclosed 2025-09-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 272,026 |
Reported balance
After 2025-09-24 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-09-24 · Sale · Disposed 550,229 · Balance 272,026 F1: This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company ("Tactic"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the "Reporting Persons"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein. The Reporting Persons are no longer subject to Section 16, except for Chandler D. Robinson, who serves as Chief Executive Officer of Monopar Therapeutics Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company ("Tactic"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the "Reporting Persons"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein. The Reporting Persons are no longer subject to Section 16, except for Chandler D. Robinson, who serves as Chief Executive Officer of Monopar Therapeutics Inc.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2026 Filed Mar 2, 2026 20:38 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | Tax withholdingCommon Stock, par value $0.02 per share | 24,417 | $70.93 | $1,731,897.81 |
DisclosureSEC source: 0001554855-26-000168 · form4.xml · nonDerivative · entry 2 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,450,716 F2 · kind: Represents shares surrendered to Euronet Worldwide, Inc. by the Reporting Person to satisfy tax withholding liability obligations associated with the vesting of performance-based restricted stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 20:38 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | GrantCommon Stock, par value $0.02 per share | 54,949 | $0.00 | $0.00 |
DisclosureSEC source: 0001554855-26-000168 · form4.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,475,133 F1 · kind: Vesting of shares from performance-based stock awards granted on December 7, 2021 (3,935), December 6, 2022 (40,345), December 12, 2023 (5,675) and December 10, 2024 (4,994). Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 18:41 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 61,277 | $0.00 Strike: $74.72 | $0.00 |
DisclosureSEC source: 0001554855-25-002228 · form4.xml · derivative · entry 7 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 61,277 shares Expires 2025-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options vested with respect to 20% of the shares on December 10, 2016 and 20% each anniversary thereafter. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 18:41 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | Tax withholdingCommon Stock, par value $0.02 per share | 60,059 | $77.49 | $4,653,971.91 |
DisclosureSEC source: 0001554855-25-002228 · form4.xml · nonDerivative · entry 2 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,420,184 Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 18:41 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | Exercise / conversionCommon Stock, par value $0.02 per share | 61,277 | $74.72 | $4,578,617.44 |
DisclosureSEC source: 0001554855-25-002228 · form4.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,480,243 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 24, 2025 Filed Sep 26, 2025 15:53 UTC | Monopar Therapeutics MNPR · Entity 5152 | SaleCommon Stock | 550,229 | $63.61 | $34,999,956.64 |
DisclosureSEC source: 0001437749-25-029925 · rdgdoc.xml · nonDerivative · entry 1 Tactic Pharma LLC · CIK 0001727357 · 10% owner Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer Brown Michael J · CIK 0001035909 · Member of 10% Owner Group O'Halloran Thomas V. · CIK 0001727481 · Member of 10% Owner Group Mazar Andrew Paul · CIK 0001727393 · Member of 10% Owner Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,026 F1 · ownership.direct: This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company ("Tactic"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the "Reporting Persons"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein. The Reporting Persons are no longer subject to Section 16, except for Chandler D. Robinson, who serves as Chief Executive Officer of Monopar Therapeutics Inc. Read SEC document |
| April 02, 2025 Filed Apr 4, 2025 19:27 UTC | Monopar Therapeutics MNPR · Entity 5152 | SaleCommon Stock | 33,334 | $35.00 | $1,166,690.00 |
DisclosureSEC source: 0001437749-25-011068 · rdgdoc.xml · nonDerivative · entry 1 Tactic Pharma LLC · CIK 0001727357 · 10% owner Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer Brown Michael J · CIK 0001035909 · Member of 10% Owner Group O'Halloran Thomas V. · CIK 0001727481 · Member of 10% Owner Group Mazar Andrew Paul · CIK 0001727393 · Member of 10% Owner Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 822,255 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.86, inclusive. The reporting person undertakes to provide to Monopar Therapeutics Inc., any security holder of Monopar Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.direct: This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company ("Tactic"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the "Reporting Persons"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 19:36 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | SaleCommon Stock, par value $0.02 per share | 95,000 | $100.69 | $9,565,550.00 |
DisclosureSEC source: 0001213900-25-024528 · ownership.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,418,966 Read SEC document |
| February 25, 2025 Filed Feb 28, 2025 00:00 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | Tax withholdingCommon Stock, par value $0.02 per share | 17,322 | $102.84 | $1,781,394.48 |
DisclosureSEC source: 0001213900-25-018234 · ownership.xml · nonDerivative · entry 2 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,513,966 F2 · kind: Represents shares surrendered to Euronet Worldwide, Inc. by the Reporting Person to satisfy tax withholding liability obligations associated with the vesting of performance-based restricted stock. Read SEC document |
| February 25, 2025 Filed Feb 28, 2025 00:00 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | GrantCommon Stock, par value $0.02 per share | 38,985 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-018234 · ownership.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,531,288 F1 · kind: Vesting of shares from performance-based stock awards granted on December 7, 2021 (27,546), December 6, 2022 (5,763) and December 12, 2023 (5,676). Read SEC document |
| December 23, 2024 Filed Feb 14, 2025 21:41 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | GiftCommon Stock, par value $0.02 per share | 14,800 | $103.75 | $1,535,500.00 |
DisclosureSEC source: 0001213900-25-014344 · ownership.xml · nonDerivative · entry 3 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,492,303 Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 23:09 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 117,431 | $104.18 Strike: $104.18 | $12,233,961.58 |
DisclosureSEC source: 0001213900-24-108506 · ownership.xml · derivative · entry 1 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,431 Underlying: Common Stock · 117,431 shares Expires 2034-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This award vests 25% per year beginning Dec 10, 2025, contingent on the Company's share price closing above $114.60 for 30 consecutive trading days during the four year measurement period. Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 22:41 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 67,122 | $0.00 Strike: $56.24 | $0.00 |
DisclosureSEC source: 0001213900-24-107042 · ownership.xml · derivative · entry 6 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 67,122 shares Expires 2024-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options vested with respect to 20% of the shares on December 10, 2015 and 20% each anniversary thereafter. Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 22:41 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | Exercise / conversionCommon Stock, par value $0.02 per share | 67,122 | $56.24 | $3,774,941.28 |
DisclosureSEC source: 0001213900-24-107042 · ownership.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,583,919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 25, 2024 Filed Feb 14, 2025 21:41 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | GiftCommon Stock, par value $0.02 per share | 2,500 | $100.50 | $251,250.00 |
DisclosureSEC source: 0001213900-25-014344 · ownership.xml · nonDerivative · entry 2 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,507,103 Read SEC document |
| September 24, 2024 Filed Feb 14, 2025 21:41 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | GiftCommon Stock, par value $0.02 per share | 1,000 | $100.39 | $100,390.00 |
DisclosureSEC source: 0001213900-25-014344 · ownership.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,509,603 F1 · balance_after: Prior filing incorrectly stated in column 5 of Table I the amount of securities beneficially owned by (i) Mr. Brown individually, (ii) Mr. Brown's spouse, (iii) family trusts for the benefit of Mr. Brown's spouse and children, of which Mr. Brown's spouse is the trustee, and (iv) Mr. Brown's spouse as custodian for his children. The amount of securities beneficially owned is corrected herein. Read SEC document |
| February 22, 2024 Filed Feb 27, 2024 02:03 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | Tax withholdingCommon Stock, par value $0.02 per share | 5,524 | $107.17 | $592,007.08 |
DisclosureSEC source: 0001213900-24-017109 · ownership.xml · nonDerivative · entry 2 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,516,797 F2 · kind: Represents shares surrendered to Euronet Worldwide, Inc. by the Reporting Person to satisfy tax withholding liability obligations associated with the vesting of performance-based restricted stock. Read SEC document |
| February 22, 2024 Filed Feb 27, 2024 02:03 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | GrantCommon Stock, par value $0.02 per share | 12,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-017109 · ownership.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,522,321 F1 · kind: Vesting of shares from performance-based stock awards granted on December 12, 2018 (1,076), December 10, 2019 (1,620), December 7, 2021 (3,935) and December 6, 2022 (5,764). Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 19:40 UTC | Monopar Therapeutics MNPR · Entity 5152 | Exercise / conversionRestricted Stock Units · Derivative | 2,533 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-000487 · rdgdoc.xml · derivative · entry 4 Brown Michael J · CIK 0001035909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,533 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F4 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 19:40 UTC | Monopar Therapeutics MNPR · Entity 5152 | Exercise / conversionCommon Stock | 2,533 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-000487 · rdgdoc.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| December 12, 2023 Filed Dec 15, 2023 02:59 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | GrantEmployee Stock Option (right to buy) · Derivative | 132,470 | $91.66 Strike: $91.66 | $12,142,200.20 |
DisclosureSEC source: 0001213900-23-095856 · ownership.xml · derivative · entry 1 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,470 Underlying: Common Stock · 132,470 shares Expires 2033-12-12 F1 · derivative.exercise_date: This award vests 25% per year beginning Dec 12, 2024, contingent on the Company's share price closing above $100.83 for 30 consecutive days during the four year measurement period. Read SEC document |
| December 04, 2023 Filed Dec 5, 2023 22:38 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 59,324 | $0.00 Strike: $45.93 | $0.00 |
DisclosureSEC source: 0001213900-23-093189 · ownership.xml · derivative · entry 7 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 59,324 shares Expires 2023-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options vested with respect to 20% of the shares on December 10, 2013 and 20% each anniversary thereafter. Read SEC document |
| December 04, 2023 Filed Dec 5, 2023 22:38 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | Tax withholdingCommon Stock, par value $0.02 per share | 43,259 | $88.87 | $3,844,427.33 |
DisclosureSEC source: 0001213900-23-093189 · ownership.xml · nonDerivative · entry 2 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,509,926 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.47 to $89.47, inclusive. The Reporting Person undertakes to provide to Euronet Worldwide, Inc., any security holder of Euronet Worldwide, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range referred herein. Read SEC document |
| December 04, 2023 Filed Dec 5, 2023 22:38 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | Exercise / conversionCommon Stock, par value $0.02 per share | 59,324 | $45.93 | $2,724,751.32 |
DisclosureSEC source: 0001213900-23-093189 · ownership.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,553,185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 13, 2023 Filed Oct 16, 2023 19:49 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,500 | $0.00 Strike: $45.93 | $0.00 |
DisclosureSEC source: 0001013762-23-004099 · ownership.xml · derivative · entry 6 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,324 Underlying: Common Stock · 8,500 shares Expires 2023-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options vested with respect to 20% of the shares on December 10, 2013 and 20% each anniversary thereafter. Read SEC document |
| October 13, 2023 Filed Oct 16, 2023 19:49 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | Exercise / conversionCommon Stock, par value $0.02 per share | 8,500 | $45.93 | $390,405.00 |
DisclosureSEC source: 0001013762-23-004099 · ownership.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,493,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 19:32 UTC | Monopar Therapeutics MNPR · Entity 5152 | Exercise / conversionRestricted Stock Units · Derivative | 2,533 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-027584 · rdgdoc.xml · derivative · entry 4 Brown Michael J · CIK 0001035909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,533 Underlying: Common Stock · 2,533 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F4 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 19:32 UTC | Monopar Therapeutics MNPR · Entity 5152 | Exercise / conversionCommon Stock | 2,533 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-23-027584 · rdgdoc.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,330 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| September 26, 2023 Filed Sep 27, 2023 20:35 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | GiftCommon Stock, par value $0.02 per share | 2,000 | $79.00 | $158,000.00 |
DisclosureSEC source: 0001213900-23-079928 · ownership.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,485,361 Read SEC document |
| June 30, 2023 Filed Jul 3, 2023 18:49 UTC | Monopar Therapeutics MNPR · Entity 5152 | Exercise / conversionRestricted Stock Units · Derivative | 2,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-019261 · rdgdoc.xml · derivative · entry 4 Brown Michael J · CIK 0001035909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,066 Underlying: Common Stock · 2,534 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F4 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| June 30, 2023 Filed Jul 3, 2023 18:49 UTC | Monopar Therapeutics MNPR · Entity 5152 | Exercise / conversionCommon Stock | 2,534 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-23-019261 · rdgdoc.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| May 22, 2023 Filed May 24, 2023 17:02 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | SaleCommon Stock, par value $0.02 per share | 6,557 | $121.23 | $794,905.11 |
DisclosureSEC source: 0001213900-23-042630 · ownership.xml · nonDerivative · entry 2 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,487,361 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.00 to $121.51, inclusive. The Reporting Person undertakes to provide to Euronet Worldwide, Inc., any security holder of Euronet Worldwide, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range referred herein. Read SEC document |
| May 22, 2023 Filed May 24, 2023 17:02 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | SaleCommon Stock, par value $0.02 per share | 43,443 | $120.61 | $5,239,660.23 |
DisclosureSEC source: 0001213900-23-042630 · ownership.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,493,918 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.00 to $121.51, inclusive. The Reporting Person undertakes to provide to Euronet Worldwide, Inc., any security holder of Euronet Worldwide, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range referred herein. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 17:19 UTC | Monopar Therapeutics MNPR · Entity 5152 | Exercise / conversionRestricted Stock Units · Derivative | 2,533 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009335 · rdgdoc.xml · derivative · entry 4 Brown Michael J · CIK 0001035909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,600 Underlying: Common Stock · 2,533 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F4 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 17:19 UTC | Monopar Therapeutics MNPR · Entity 5152 | Exercise / conversionCommon Stock | 2,533 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-23-009335 · rdgdoc.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 22:27 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | GrantCommon Stock, par value $0.02 per share | 7,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-23-014432 · ownership.xml · nonDerivative · entry 2 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,537,361 F1 · kind: Vesting of shares from performance-based stock awards granted on December 12, 2017 (1,304), December 12, 2018 (1,077), December 10, 2019 (1,621) and December 7, 2021 (3,935). Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 22:27 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | GiftCommon Stock, par value $0.02 per share | 988 | $107.56 | $106,269.28 |
DisclosureSEC source: 0001213900-23-014432 · ownership.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,529,424 Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 21:38 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | GiftCommon Stock, par value $0.02 per share | 2,000 | $115.45 | $230,900.00 |
DisclosureSEC source: 0001213900-23-007397 · ownership.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,530,412 Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 18:50 UTC | Monopar Therapeutics MNPR · Entity 5152 | GrantRestricted Stock Units · Derivative | 10,133 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-002519 · rdgdoc.xml · derivative · entry 2 Brown Michael J · CIK 0001035909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,133 Underlying: Common Stock · 10,133 shares Expires not disclosed F2 · derivative.exercise_date: RSUs vest 25% quarterly on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023. F2 · derivative.expiration_date: RSUs vest 25% quarterly on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 18:50 UTC | Monopar Therapeutics MNPR · Entity 5152 | GrantStock Options · Derivative | 13,930 | $0.00 Strike: $3.16 | $0.00 |
DisclosureSEC source: 0001437749-23-002519 · rdgdoc.xml · derivative · entry 1 Brown Michael J · CIK 0001035909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,930 Underlying: Common Stock · 13,930 shares Expires 2033-02-01 F1 · derivative.exercise_date: Options vest 25% quarterly on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023. Read SEC document |
| December 31, 2022 Filed Jan 3, 2023 16:10 UTC | Monopar Therapeutics MNPR · Entity 5152 | Exercise / conversionRestricted Stock Units · Derivative | 2,859 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-000172 · rdgdoc.xml · derivative · entry 4 Brown Michael J · CIK 0001035909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,859 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F4 · derivative.exercise_date: On February 2, 2022, the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.expiration_date: On February 2, 2022, the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| December 31, 2022 Filed Jan 3, 2023 16:10 UTC | Monopar Therapeutics MNPR · Entity 5152 | Exercise / conversionCommon Stock | 2,859 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-23-000172 · rdgdoc.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,730 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| December 27, 2022 Filed Dec 29, 2022 18:30 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | GiftCommon Stock, par value $0.02 per share | 220 | $93.37 | $20,541.40 |
DisclosureSEC source: 0001213900-22-083459 · ownership.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,532,192 Read SEC document |
| December 13, 2022 Filed Dec 14, 2022 22:03 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | GiftCommon Stock, par value $0.02 per share | 2,000 | $92.37 | $184,740.00 |
DisclosureSEC source: 0001213900-22-079829 · ownership.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,532,412 Read SEC document |
| December 06, 2022 Filed Dec 9, 2022 00:42 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | GrantEmployee Stock Option (right to buy) · Derivative | 141,290 | $90.26 Strike: $90.26 | $12,752,835.40 |
DisclosureSEC source: 0001213900-22-078552 · ownership.xml · derivative · entry 6 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,290 Underlying: Common Stock · 141,290 shares Expires 2032-12-06 F4 · derivative.exercise_date: This award vests 25% per year beginning Dec 6, 2023, contingent on the Company's share price closing above $99.29 for 30 consecutive days during the four year measurement period. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 18:11 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 76,844 | $0.00 Strike: $23.63 | $0.00 |
DisclosureSEC source: 0001213900-22-077150 · ownership.xml · derivative · entry 6 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 76,844 shares Expires 2022-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vested with respect to 20% of the shares on December 11, 2013 and 20% each anniversary thereafter. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 18:11 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | Exercise / conversionCommon Stock, par value $0.02 per share | 76,844 | $23.63 | $1,815,823.72 |
DisclosureSEC source: 0001213900-22-077150 · ownership.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,534,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:26 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | GiftCommon Stock, par value $0.02 per share | 5,400 | $89.40 | $482,760.00 |
DisclosureSEC source: 0001213900-22-074641 · ownership.xml · nonDerivative · entry 4 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,457,363 Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:26 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | GiftCommon Stock, par value $0.02 per share | 5,000 | $89.40 | $447,000.00 |
DisclosureSEC source: 0001213900-22-074641 · ownership.xml · nonDerivative · entry 3 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,462,763 Read SEC document |
| November 18, 2022 Filed Nov 22, 2022 22:26 UTC | EURONET WORLDWIDE, INC. EEFT · Entity 4336 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $23.63 | $0.00 |
DisclosureSEC source: 0001213900-22-074641 · ownership.xml · derivative · entry 9 Brown Michael J · CIK 0001035909 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,844 Underlying: Employee Stock Option (right to buy) · 25,000 shares Expires 2022-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option vests with respect to 20% of the shares on December 11, 2013 and 20% each anniversary thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.